BlackRock’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
BlackRock's ELV Position: Q1 2026 in Review
BlackRock reduced its Elevance Health (ELV) stake by 2.5% in Q1 2026, selling an estimated $169M and leaving 19,887,111 shares worth $5.82B. The position accounts for 0.1% of the portfolio, ranked #174.
BlackRock first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.2B in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- BlackRock held 19,887,111 shares of Elevance Health worth $5.82B as of Q1 2026.
- BlackRock sold 515,523 Elevance Health shares in Q1 2026, an estimated $169M.
- Elevance Health made up 0.1% of BlackRock's portfolio in Q1 2026, its #174 holding.
- BlackRock first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- BlackRock's Elevance Health position peaked at $11.2B in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.